The International Trade Commission is beginning a Section 337 investigation on photovoltaic trunk bus cable assemblies (ITC Inv. No. 337-TA-1438) after receiving allegations filed by Shoals Technologies Group that U.S. company Voltage and Chinese company Ningbo Voltage Smart Production are importing products that infringe its patents, the agency said in a notice to be published Feb. 18.
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website Feb. 13, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
The International Trade Commission published notices in the Feb. 13 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
A domestic producer recently filed a petition with the Commerce Department and the International Trade Commission requesting new antidumping and countervailing duties on methylene diphenyl diisocyanate from China. Commerce will now decide whether to begin AD/CVD investigations, which could result in the imposition of permanent AD/CVD orders and the assessment of AD and CVD on importers. The Ad Hoc MDI Fair Trade Coalition, which consists of the BASF Corporation and The Dow Chemical Company, requested the investigation.
The International Trade Commission published notices in the Feb. 12 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission published notices in the Feb. 11 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission published notices in the Feb. 7 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
President Donald Trump, speaking to reporters during a Feb. 7 press conference with Japan's Prime Minister, said that he would probably announce, either Monday or Tuesday, Feb. 10 or Feb. 11, "reciprocal tariffs where a country pays so much or charges us so much and we do the same, so very reciprocal because I think that's the only fair way to do it, that way nobody's hurt. They charge us, we charge them."
The International Trade Commission published notices in the Feb. 6 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission is issuing a limited exclusion order banning imports of medical admixture devices (ITC Inv. No. 337-TA-1362) from U.S. company Summit International Medical Technologies, Advcare Medical of Taiwan, and Dragon Heart of China, it said in a notice to be published Feb. 7. Additionally, the ITC issued cease and desist orders against Summit International but imposed no bond for covered articles imported or sold during the period of presidential review. The order concludes a Section 337 investigation the ITC launched in May 2023, based on allegations by West Pharmaceutical Services of Pennsylvania and West Pharma of Israel that the respondents are importing fluid transfer devices that have a trifurcated connector body with an integral vial adapter (see 2305100005) that copy and infringe its patented designs.